Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Raloxifene and estrogen: comparative bone-remodeling kinetics

R P Heaney1, M W Draper

  • 1Creighton University, Omaha, Nebraska 68178, USA.

The Journal of Clinical Endocrinology and Metabolism
|November 5, 1997
PubMed
Summary

Raloxifene and estrogen similarly impact bone remodeling in postmenopausal women by reducing bone resorption. Raloxifene acts as an estrogen agonist on bone, showing comparable effects to hormone replacement therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Achieving the protection of high peak bone mass.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same author

Incidence rate of type 2 diabetes is >50% lower in GrassrootsHealth cohort with median serum 25-hydroxyvitamin D of 41 ng/ml than in NHANES cohort with median of 22 ng/ml.

The Journal of steroid biochemistry and molecular biology·2015
Same author

Vitamin D supplementation in multiple sclerosis: making a case for clarity.

Journal of the neurological sciences·2014
Same author

Toward a physiological referent for the vitamin D requirement.

Journal of endocrinological investigation·2014
Same author

Chronic dietary fiber supplementation with wheat dextrin does not inhibit calcium and magnesium absorption in premenopausal and postmenopausal women.

The Journal of international medical research·2011
Same author

The effect of vitamin D dose on bone mineral density.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2011

Area of Science:

  • Endocrinology
  • Bone Biology
  • Pharmacology

Background:

  • Osteoporosis is a significant concern in postmenopausal women.
  • Hormone replacement therapy (HRT) with estrogen is a common treatment.
  • Raloxifene is a selective estrogen receptor modulator (SERM) with potential bone benefits.

Purpose of the Study:

  • To compare the effects of raloxifene and estrogen on human bone remodeling.
  • To determine if raloxifene acts as an estrogen agonist on bone.

Main Methods:

  • Calcium tracer kinetic methods were used in 33 early postmenopausal women.
  • Participants were randomly assigned to raloxifene, estrogen, or no treatment.
  • Bone remodeling was assessed at baseline, 4 weeks, and 31 weeks.

Main Results:

  • Both raloxifene and estrogen significantly increased positive calcium balance.
  • Urinary calcium levels decreased, and calcium absorption marginally improved.
  • Bone resorption was significantly reduced by both agents.
  • Estrogen reduced bone formation at 31 weeks, while raloxifene did not.

Conclusions:

  • Raloxifene and estrogen exhibit similar patterns of bone remodeling changes.
  • Raloxifene demonstrates estrogen agonist activity on the bone remodeling apparatus.
  • Both treatments effectively suppress bone resorption in early postmenopausal women.

Related Experiment Videos